Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 172500
Corporate User License Price USD 7500
Corporate User License Price INR 517500
Site License Price USD 5000
Site License Price INR 345000
Request a Quote

Report Title

Adenomas Global Clinical Trials Review, H2, 2018

Quote Request for License Type
License Type Price  
Single User License USD 2500
Site License USD 5000
Enterprise Wide License USD 7500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Adenomas Global Clinical Trials Review, H2, 2018


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Adenomas Global Clinical Trials Review, H2, 2018

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Adenomas Global Clinical Trials Review, H2, 2018



Executive Summary

Adenomas Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, Adenomas Global Clinical Trials Review, H2, 2018" provides an overview of Adenomas clinical trials scenario. This report provides top line data relating to the clinical trials on Adenomas. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Adenomas to Non Malignant Disorders Clinical Trials 16

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Adenomas to Non Malignant Disorders Clinical Trials 21

Clinical Trials by Phase in E7 Countries 23

Clinical Trials in E7 Countries by Trial Status 24

Clinical Trials by Phase 25

In Progress Trials by Phase 26

Clinical Trials by Trial Status 27

Clinical Trials by End Point Status 29

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Adenomas Therapeutics Clinical Trials 34

Prominent Drugs 36

Clinical Trial Profile Snapshots 37

Appendix 121

Abbreviations 121

Definitions 121

Research Methodology 122

Secondary Research 122

About GlobalData 122

Contact Us 123

Source 123

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Adenomas Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Adenomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Adenomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Adenomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11

Adenomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

Adenomas Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Adenomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14

Proportion of Adenomas to Non Malignant Disorders Clinical Trials, G7 Countries (%), 2018* 16

Adenomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18

Adenomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19

Proportion of Adenomas to Non Malignant Disorders Clinical Trials, E7 Countries (%), 2018* 21

Adenomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23

Adenomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24

Adenomas Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25

Adenomas Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26

Adenomas Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27

Adenomas Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29

Adenomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30

Adenomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31

Adenomas Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32

Adenomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34

Adenomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

GlobalData Methodology 122

List of Tables

Adenomas Therapeutics, Global, Clinical Trials by Region, 2018* 7

Adenomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Adenomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Adenomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11

Adenomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

Adenomas Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Adenomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14

Adenomas Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15

Proportion of Adenomas to Non Malignant Disorders Clinical Trials, G7 Countries (%), 2018* 17

Adenomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18

Adenomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20

Proportion of Adenomas to Non Malignant Disorders Clinical Trials, E7 Countries (%), 2018* 22

Adenomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23

Adenomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24

Adenomas Therapeutics, Global, Clinical Trials by Phase, 2018* 25

Adenomas Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26

Adenomas Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28

Adenomas Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29

Adenomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30

Adenomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31

Adenomas Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33

Adenomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35

Adenomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Novartis AG

Ipsen SA

Dr. Falk Pharma GmbH

Daiichi Sankyo Co Ltd

Colotech A/S

Changi General Hospital Pte Ltd

Cancer Research Network, Inc

AstraZeneca Plc

Aptalis Pharmatech Inc

Amgen Inc

Adenomas Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Adenomas, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person